Seit 1989 hat Advent im Rahmen von Private-Equity-Transaktionen in über 335 Unternehmen in 40 Ländern investiert.
| Company | Land | Sektor | Description | Deal-Art | Invest. date | |
|---|---|---|---|---|---|---|
 |
Zentiva | Land Czech Republic | Sektor Healthcare | Description A leading European generics pharmaceutical company, offering generic medicines across all key therapeutic areas | Deal-Art Carve-out | Invest. date Sep 2018 |
 |
Genoa Healthcare | Land US | Sektor Healthcare | Description Largest specialty pharmacy operator in the US focusing primarily on serving the needs of the mental health community | Deal-Art Buyout | Invest. date Apr 2015 |
 |
Mediq | Land Netherlands | Sektor Healthcare | Description Global provider of pharmaceuticals, medical devices and related care services | Deal-Art Public-to-private | Invest. date Feb 2013 |
 |
Grupo Biotoscana | Land Colombia | Sektor Healthcare | Description Specialty pharmaceutical company licensing innovative and niche products to market in Latin America | Deal-Art Buyout | Invest. date Nov 2011 |
 |
Laboratorio LKM | Land Argentina | Sektor Healthcare | Description One of the leading specialty pharmaceutical manufacturers in Argentina | Deal-Art Buyout | Invest. date Oct 2011 |
 |
Labormed | Land Romania | Sektor Healthcare | Description Romanian pharmaceutical manufacturer and distributor | Deal-Art Buyout | Invest. date Feb 2008 |
 |
Terapia | Land Romania | Sektor Healthcare | Description Romania's largest independent generic pharmaceuticals manufacturer | Deal-Art Public-to-private | Invest. date Aug 2003 |
 |
Aviagen | Land UK | Sektor Healthcare | Description World's leading meat poultry breeding company | Deal-Art Buyout | Invest. date May 2003 |
 |
Viatris | Land Deutschland | Sektor Healthcare | Description Entwicklung, Herstellung, Vertrieb und Einlizenzierung von Marken-Arzneimitteln | Deal-Art Buyout | Invest. date Aug 2002 |
 |
Fada Pharma | Land Argentina | Sektor Healthcare | Description Argentina's leading manufacturer of generic pharmaceuticals for the institutional market | Deal-Art Buyout | Invest. date Jan 2001 |
 |
Tropon | Land Deutschland | Sektor Healthcare | Description Lohnfertiger und Anbieter von Arzneimitteln zur Behandlung entzündlicher und rheumatischer Beschwerden (vom Advent Portfolio-Unternehmen Viatris übernommen) | Deal-Art Buyout | Invest. date Mar 2000 |
 |
Alcala Farma | Land Spain | Sektor Healthcare | Description Manufacturer and marketer of own and in-licensed pharmaceuticals, branded generics and over-the-counter products | Deal-Art Growth equity | Invest. date Sep 1999 |
 |
Trinity Pharmaceuticals | Land UK | Sektor Healthcare | Description Co-development, licensing and marketing of branded pharmaceuticals, mainly for cardiovascular and arthritic indications | Deal-Art Buyout | Invest. date Mar 1997 |
 |
3i - Implant Innovations Inc. | Land US | Sektor Healthcare | Description Manufacturer of dental implants | Deal-Art Growth equity | Invest. date May 1995 |
 |
Telik | Land US | Sektor Healthcare | Description Developer of novel pharmaceuticals to treat cancer and metabolic diseases (merged with MabVax Therapeutics) | Deal-Art Growth equity | Invest. date Nov 1994 |
 |
Esaote Biomedica | Land Italy | Sektor Healthcare | Description Research, production and marketing of imaging and non-imaging medical diagnostic equipment | Deal-Art Buyout | Invest. date Jul 1994 |
 |
Transcend Therapeutics | Land US | Sektor Healthcare | Description Company formed to develop novel pharmaceuticals for the critical-care market | Deal-Art Growth equity | Invest. date Apr 1994 |
© 2002-2019 Advent International Corporation. All rights reserved
